Results 191 to 200 of about 16,238 (237)

Muckle Wells syndrome as an example of hereditary systemic autoinflammatory disease [PDF]

, 2014
Bertomeu Tomàs, Andrea, Universitat Autònoma de Barcelona. Facultat de Biociències   +1 more
core  

Tribulations of Randomized Controlled Trials: Testing the Inflammatory Hypothesis of Heart Failure. [PDF]

Circ Heart Fail
Buckley LF, Weber BN.
europepmc   +1 more source

Long-term follow-up after discontinuation of anti-IL1 treatment in colchicine-resistant familial Mediterranean fever. [PDF]

Rheumatology (Oxford)
Cam V, Bayindir Y, Bilginer Y, Ozen S.
europepmc   +1 more source

Anti-inflammatory pharmacotherapy in patients with cardiovascular disease. [PDF]

Eur Heart J Cardiovasc Pharmacother
Finocchiaro S, Mazzone PM, Ammirabile N, Bordonaro C, Cusmano C, Cutore L, Di Leo G, Faro DC, Giacoppo D, Greco A, Imbesi A, Mauro MS, Raffo C, Spagnolo M, Capodanno D.   +14 more
europepmc   +1 more source

Impact of Interleukin-1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification Criteria. [PDF]

Arthritis Rheumatol
Erkens RGA, Rogani G, Huber L, Verwoerd A, Schonenberg-Meinema D, van den Berg JM, Armbrust W, Legger GE, Kamphuis S, Schatorjé EJH, Hoppenreijs EPAH, Swart JF, Jansen MHA, van Loosdregt J, Vastert SJ.   +14 more
europepmc   +1 more source

Managing Yao Syndrome: A Case of Beneficial Treatment with Upadacitinib and Leflunomide. [PDF]

Mediterr J Rheumatol
Hasbani GE, Davis JM.
europepmc   +1 more source

A Randomized, Double-blind, Placebo Controlled, Withdrawal Study of Flare Prevention of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations

Novartis
openalex   +1 more source

Case Report: Mevalonate kinase deficiency: an underdiagnosed cause of ischemic stroke-characterization of a novel genetic variant. [PDF]

Front Immunol
Hamidi LN, Drda JC, Belhocine M, Elfassy HL, Ducharme-Bénard S, Chayer-Lanthier M, Sultana B, Lanthier S.   +7 more
europepmc   +1 more source

From Bench to Clinic: Advances in Anti-Inflammatory Therapies for Atherosclerotic Coronary Artery Disease. [PDF]

FASEB J
Wang K, Yin Z, Zhang Y, Wu X, Fan L.
europepmc   +1 more source

Efficacy of new immunomodulatory drugs on major adverse cardiovascular events in patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials. [PDF]

BMC Cardiovasc Disord
He D, Li Y, Jiang Z, Cao X, Luo R.
europepmc   +1 more source